Impact of psychosocial issues on cervical cancer prevention among Chinese women in Hong Kong
|
|
- Catherine Blake
- 6 years ago
- Views:
Transcription
1 Impact of psychosocial issues on cervical cancer prevention among Chinese women in Hong Kong Annie NY CHEUNG MBBS, MD, PhD, FRCPath, FHKAM(Path), FIAC, IFCAP Laurence L T Hou Professorship in Anatomical Molecular Pathology Department of Pathology, The University of Hong Kong Queen Mary Hospital, Hong Kong
2 Disclosures No financial relationships or conflict of interest to disclose
3 CHINA Hong Kong Area: 1,104 km 2 Population: 7,234,800
4 Trend of Age-standardised Incidence and Mortality Rates of Cervical Cancer in Hong Kong, new cases (2014), 131 death (2014) Rank 8 th in incidence and 9 th in mortality A successful example of opportunistic screening. Dept of Health, HKSAR 2017 Cancer Registry, HA, HKSAR
5 Impact of psychosocial issues on cervical cancer prevention among Chinese women in Hong Kong Barriers and facilitators to HPV vaccination among Chinese adolescent girls Acceptability of HPV vaccination among Chinese women Effect of de-stigmatising Effect of school-based cervical cancer education on perceptions towards HPV vaccination Psychological burden of positive high-risk HPV on women with atypical cervical cytology HPV vaccine: what are women most concerned about Assessment of knowledge and stigmatizing attitudes related to HPV among Hong Kong Chinese healthcare providers.
6 Barriers and facilitators to HPV vaccination among Chinese adolescent girls in Hong Kong Study to explore perceptions towards cervical cancer, HPV infection and HPV vaccination and to identify factors affecting the acceptability of HPV vaccination among Chinese adolescent girls in Hong Kong. Focus groups were conducted with Chinese adolescent girls in Hong Kong. Thematic analysis was employed to identify major themes related to cervical cancer and HPV vaccination. A supplementary questionnaire was administered to all participants before and after group discussion to assess their knowledge, attitudes and intention to be vaccinated and to collect demographic information. Kwan et al. Sex Transm Infect. 2008
7 Kwan et al. Sex Transm Infect. 2008
8 Kwan et al. Sex Transm Infect. 2008
9 Kwan et al. Sex Transm Infect. 2008
10 Barriers and facilitators to HPV vaccination among Chinese adolescent girls in Hong Kong Participants' knowledge on cervical cancer was limited and HPV was largely unheard of. They had difficulty understanding the mechanism linking cervical cancer with HPV infection. Participants held a favourable attitude towards HPV vaccination but the perceived timing of vaccination varied. The differences on knowledge, attitudes, intention to be vaccinated now and willingness to conform to significant others before and after the discussion were statistically significant, with an increased tendency towards favouring vaccination after the focus group. Kwan et al. Sex Transm Infect. 2008
11 Barriers and facilitators to HPV vaccination among Chinese adolescent girls in Hong Kong Barriers to vaccination high monetary cost uncertain length of vaccine effectiveness low perceived risk of HPV infection no immediate perceived need of vaccination anticipated family disapproval fear of the pain of injection. Facilitators to vaccination perceived family and peer support and medical reassurance on safety and efficacy of vaccine Kwan et al. Sex Transm Infect. 2008
12 Acceptability of HPV vaccination among Chinese women: concerns and implications Ethnic Chinese women 18 attended community women's health centres. 1/3 participants had heard of HPV and 1/2 had heard of vaccination against cervical cancer. HPV infection was perceived to be stigmatising and detrimental to intimate, family and social relationships. 88% of the participants indicated wish to be vaccinated. Majority of the participants believed that sexually experienced women should be vaccinated, while 27% opposed vaccinating sexually naive women. Younger age women who perceived a disruptive impact of HPV infection on intimate relationship and their partners' approval were significantly associated with a positive intention to be HPV vaccinated. Kwan et al. BJOG. 2009
13 Kwan et al. BJOG. 2009
14 Kwan et al. BJOG. 2009
15 Acceptability of HPV vaccination among Chinese women: concerns and implications There is a dire need for culturally sensitive and tailored education for the public, women of different ages and their partners about HPV and HPV vaccination. Emphasis must be placed on the prophylactic nature of the current vaccines, the uncertain effects when given to sexually experienced women, the importance of adolescent vaccination and the need for continued cervical screening whether vaccinated or not. Kwan et al. BJOG. 2009
16 De-stigmatising HPV in the context of cervical cancer Study to identify the components of a HPV message contributing to the stigma of HPV in cervical cancer. Chinese women attending a community-based clinic in Hong Kong were randomly allocated to read 1 of 3 written HPV messages: 1. Group 'lr+hrhpv': low-risk and high-risk HPVs facts 2. Group 'hrhpv': high-risk HPV facts only 3. Group 'ds+hrhpv': high-risk HPV facts and de-stigmatising components, namely being anti-stereotypical, motivational and low in complexity Main outcome measures were high-risk HPV-related sexual stigma, knowledge, attitude towards message, and intention to be HPV-tested measured by selfadministered questionnaires immediately before and after reading. Kwan et al. Psychooncology. 2010
17 De-stigmatising HPV in the context of cervical cancer Message allocation had a significant effect on sexual stigma. Kwan et al. Psychooncology Participants who read message ds+hrhpv showed the least stigma, and were significantly less likely to believe that high-risk HPV infection implicated promiscuity, non-monogamy or that monogamy offered complete protection against high-risk HPV. The genital HPV-focused message was more stigmatising than cervical cancerfocused messages. HPV message containing specific de-stigmatising components may reduce public stigma towards high-risk HPV. Focusing solely on high-risk HPV in the context of cervical cancer helps to avoid the stigmatising effect of genital warts from tainting perceptions about high-risk HPV infection.
18 The effect of school-based cervical cancer education on perceptions towards HPV vaccination among Hong Kong Chinese adolescent girls Study to evaluate the effects of school-based cervical cancer education on Hong Kong Chinese adolescent girls. Local secondary school students attended a tailored educational program on cervical cancer prevention. Self-administered questionnaires were used before and after the program. Kwan et al. Patient Educ Couns. 2011
19 Kwan et al. Patient Educ Couns. 2011
20 Before the program, HPV vaccine acceptance was favorable but relevant knowledge was low. After the program, participants had greater knowledge and a more positive attitude, with more girls anticipating family. There were more girls who indicated an intention to accept the vaccine afterward. Kwan et al. Patient Educ Couns. 2011
21 Kwan et al. Patient Educ Couns. 2011
22 The effect of school-based cervical cancer education on perceptions towards HPV vaccination among Hong Kong Chinese adolescent girls More knowledge, a more positive attitude and perceived support from significant others predicted a stronger intention to be HPV vaccinated. Educational program had a positive impact on participants perceptions towards HPV vaccination and their intention to be vaccinated. School-based cervical cancer education is a viable means to meet the substantial educational needs of adolescents. Promotion of HPV vaccination should include educating and influencing perceptions of families and peers. Kwan et al. Patient Educ Couns. 2011
23 HPV test for Triage of atypical squamous of undetermined significance (ASCUS) ASCUS was found in 3-4% of cervical cytology. ASCUS account for 60-80% of all abnormal cytology Women with ASCUS has higher risk of subsequent confirmation of LSIL or HSIL compared with general women population Cheung et al. Cancer Cytopathology 2004
24 HPV test for Triage of ASCUS anxiety of patients cost of repeat smears Earlier diagnosis of HSIL + cases HKCOG Guidelines 2002, 2008, 2016
25 Psychological burden of testing positive for high-risk HPV on women with ASC-US At result notification, the HPV +ve group had significantly higher state anxiety, cervical cancer worry and psychosocial burden than the HPV neg group. Irrespective of the HPV results, all outcome scores over time. At 6 months, no difference between the 2 in state anxiety, cervical cancer worry, perceived risk of cervical cancer and satisfaction with intimate relationship. Psychosocial burden remained higher in the HPV-positive group Kwan et al. Acta Obstet Gynecol Scand. 2011
26 Kwan et al. Acta Obstet Gynecol Scand. 2011
27 Knowledge and stigmatizing attitudes related to HPV among Hong Kong Chinese healthcare providers. Questionnaire to doctors, nurses, and smear-taking trainees providing cervical screening in Hong Kong. Most participants had basic knowledge about HPV infection and HPV vaccination. 1/3 knew that HPV infection is most common among young women, or infected individuals might not have any identifiable sexual risk factors. 1/3 agreed that individuals with HPV infection were sexually easy, responsible for their infection, or had more than 1 sexual partner. A lack of understanding of the indications for HPV testing and the implications of a positive result. Continued education on HPV and HPV testing is needed for frontline healthcare providers of screening in Hong Kong. More knowledge about HPV infection predicted less stigmatizing attitudes. Kwan et al. Int J Gynaecol Obstet. 2012
28 HPV vaccine: what are women most concerned about? Chan et al. J Obstet Gynaecol Res A cross-sectional questionnaire survey conducted in 1450 women attending outpatient family planning clinics in Hong Kong to investigate the areas of concerns that women have regarding HPV vaccination.
29 Top 3 factors that most women felt very important were: - vaccine effectiveness (45.4%) - effect duration (44.0%) - long-term side-effects(43.7%) Chan et al. J Obstet Gynaecol Res. 2012
30 - Education level significantly affected the degree of concerns in these areas - Income was significantly inversely associated with the importance of cost and effectiveness. Chan et al. J Obstet Gynaecol Res. 2012
31 Chan et al. J Obstet Gynaecol Res. 2012
32 HPV vaccine: what are women most concerned about? Chan et al. J Obstet Gynaecol Res A cross-sectional questionnaire survey conducted in 1450 women attending outpatient family planning clinics in Hong Kong to investigate the areas of concerns that women have regarding HPV vaccination. Such issues should be specifically addressed when vaccine information is given, bearing in mind the particular concerns in women with different socio-economic backgrounds.
33 Summary Continued education on cervical cancer, HPV vaccine and HPV testing is necessary for general public including females of different age groups and male population as well as frontline healthcare providers in Hong Kong. It is necessary to raise adolescents' perceived need to take preventive measures against HPV infection. De-stigmatising messages should be considered in education material to enhance compliance to HPV vaccinations and tests.
34 Thank you!!
HPV Knowledge Survey Healthcare Providers
1. What is your age? m 20-24 m 25-35 m 36-45 m 46-55 m 56-65 m 66-75 2. What is your gender? m Male m Female m Other 3. Which ethnic group do you identify with (please tick all that apply)? m New Zealand
More informationThere are two supplemental tables presented here. The first, Table A.1, compares the items in the
Appendix There are two supplemental tables presented here. The first, Table A.1, compares the items in the modified Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS) to those included in the
More informationEuropean Union survey on organization and quality control of cervical cancer screening and HPV vaccination programs
European Union survey on organization and quality control of cervical cancer screening and HPV vaccination programs Introduction to the Survey The purpose of this project is to collect information regarding
More informationX-Treme Primary Care: HPV and STIs. Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers
X-Treme Primary Care: HPV and STIs Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers Learning Objectives Review recommendations for HPV related cancer screening in
More informationAppropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines
Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines Tim Kremer, MD Ralph Anderson, MD 1 Objectives Describe the natural history of HPV particularly as it relates
More informationSMALL DESIGN SMART INNOVATION
SMALL DESIGN SMART INNOVATION The new Touch and Ultra Changing the Face of Colposcopy Significant improvements have changed the cervical cancer screening pathway over the last 20 years, resulting in high
More informationHPV and the Projected Health Policy. Saman Aziz MD, MHPE, MPH University of Illinois at Chicago
HPV and the Projected Health Policy Saman Aziz MD, MHPE, MPH University of Illinois at Chicago Background Preventive care and health education promote health and disease prevention. HPV is a virus passed
More informationH uman papillomavirus (HPV) is a common sexually
155 IN PRACTICE The association between knowledge of HPV and feelings of stigma, shame and anxiety J Waller, L A V Marlow, J Wardle... Sex Transm Infect 2007;83:155 159. doi: 10.1136/sti.2006.023333 See
More information(Appendix 1) Hong Kong HIV Stigma Watch Brief Report. Basic Demographics
(Appendix 1) Hong Kong HIV Stigma Watch Brief Report Basic Demographics 291 people living with HIV (PLHIV) were recruited in the study. 96% (n=277) of the participants were male and majority (95%, n=271)
More informationCervical Cancer Screening
Todd R. Jenkins, MD, MSHA Senior Vice Chair Director, Division of Women s Reproductive Healthcare Learning Objectives Describe the etiology, natural history, and usage of the human papillomavirus (HPV)
More informationImplementation of a Research-Robust Colposcopy Management Program within the Electronic Medical Record System
Implementation of a Research-Robust Colposcopy Management Program within the Electronic Medical Record System Lonky NM*, Cannizzaro N, Xu L, Castaneda A, Stowe T, Hawk S, Chao C Southern California Permanente
More informationScreening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA
Screening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA Cancer Care Ontario Cervical Cancer Screening Goals Increase patient participation in cervical screening Increase primary care
More informationH uman papillomavirus (HPV) is a common sexually
IN PRACTICE The association between knowledge of HPV and feelings of stigma, shame and anxiety J Waller, L A V Marlow, J Wardle... See end of article for authors affiliations... Correspondence to: Dr Jo
More informationUsing knowledge interventions to determine stress and future preventative behaviour regarding cervical cancer and the human papilloma virus
Using knowledge interventions to determine stress and future preventative behaviour regarding cervical cancer and the human papilloma virus Clare Austin (Psychology) Cervical cancer, the human papilloma
More informationSamuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida
Making sense of the new Pap smear screening guidelines. Samuel B. Wolf, D.O., F.A.C.O.G. Emerald Coast Obstetrics and Gynecology Panama City Florida Case 17 year old G1P0010 with first sexual encounter
More informationAcceptability of human papillomavirus vaccination among Chinese women: concerns and implications
DOI: 10.1111/j.1471-0528.2008.01988.x www.blackwellpublishing.com/bjog Gynaecological oncology Acceptability of human papillomavirus vaccination among Chinese women: concerns and implications TTC Kwan,
More informationUpdate on Cervical Cancer Screening. Rahmouna Farez M.D. Assistant Professor, Medical College of Wisconsin 5/2/2014
Update on Cervical Cancer Screening Rahmouna Farez M.D. Assistant Professor, Medical College of Wisconsin 5/2/2014 Objectives Review the natural history of HPV as it relates to cervical cancer screening
More informationUpdate on Cervical Cancer Screening
Update on Cervical Cancer Screening Rahmouna Farez M.D. Assistant Professor, Medical College of Wisconsin 5/2/2014 Objectives Review the natural history of HPV as it relates to cervical cancer screening
More informationPortinari: A Data Exploration Tool to Personalize Cervical Cancer Screening
Portinari: A Data Exploration Tool to Personalize Cervical Cancer Screening Sagar Sen, Manoel Horta Ribeiro, Raquel C. de Melo Minardi, Wagner Meira Jr., Mari Nygård Certus V&V Center and HPV Research
More informationCervical Cancer Screening Update. Melissa Hartman, DO Women s Health
Cervical Cancer Screening Update Melissa Hartman, DO Women s Health Previous Cervical Cancer Screening Organization Recommendation ACS (2011) ACP (2008) NCI (2003) Age 21 or 3 years after first intercourse
More informationSpeaker Notes: Qualitative Methods in Dissemination and Implementation Research
Speaker Notes: Qualitative Methods in Dissemination and Implementation Research PART 3: DISSEMINATION CASE STUDY Slide 1: Dissemination Case Study Welcome to Qualitative Methods in Dissemination and Implementation
More informationRisk : How does it define cervical cancer screening?
Risk : How does it define cervical cancer screening? Alan G. Waxman, MD, MPH Dept. of Obstetrics and Gynecology University of New Mexico The University of New Mexico Disclosures I have no commercial interests
More informationH uman papilloma virus (HPV) is a common sexually
Sexually Transmitted Infections st23333 Module 1 31/10/06 11:31:11 Topics: ORIGINAL ARTICLE The association between knowledge of HPV and feelings of stigma, shame and anxiety J Waller, L Marlow, J Wardle...
More informationBRITISH COLUMBIA S CERVICAL CANCER SCREENING PROGRAM
BRITISH COLUMBIA S CERVICAL CANCER SCREENING PROGRAM DATE: NOVEMBER 19, 2016 PRESENTER: DR. DIRK VAN NIEKERK 1 Conflict of Interest Disclosure Nothing to disclose 2 ..in the beginning of the malady it
More informationYour Colposcopy Visit
Introduction Welcome to the colposcopy clinic. This booklet tells you about. The colposcopy examination.. Tests that are done in the colposcopy clinic.. What these tests look for Take a few minutes to
More informationCervical Testing and Results Management. An Evidenced-Based Approach April 22nd, Debora Bear, MSN, MPH
Cervical Testing and Results Management An Evidenced-Based Approach April 22nd, 2010 Debora Bear, MSN, MPH Assistant Medical Director for Planned Parenthood of New Mexico, Inc. Burden of cervical cancer
More informationJMSCR Vol 04 Issue 03 Page March 2016
www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 5.88 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: http://dx.doi.org/10.18535/jmscr/v4i3.08 Awareness of HPV, Cervical Cancer and Preventive
More informationPushing the Boundaries of the Lab Diagnosis in Asia
Pushing the Boundaries of the Lab Diagnosis in Asia Diana Lim MBBS, FRCPA, FRCPath (UK) Senior Consultant National University Health System and National University of Singapore Department of Pathology
More informationA Cross Sectional Study on Knowledge, Attitude and Practice of Cervical Cancer Screening Among Women in Thiruvanmiyur, Chennai
A Cross Sectional Study on Knowledge, Attitude and Practice of Cervical Cancer Screening Among Women in Thiruvanmiyur, Chennai Sneha Sethumadhavan (1), Chitra. A (1) Abstract Aims: To assess the knowledge,
More informationSUPPLEMENTARY MATERIAL
SUPPLEMENTARY MATERIAL HPV Knowledge items HPV knowledge HPV is very rare (F) HPV always has visible signs or symptoms (F) HPV can cause cervical cancer HPV can be passed on by genital skin-to-skin contact
More informationObjectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies
Cervical Cancer Screening Guidelines: Updates and Controversies I have no financial interests in any product I will discuss today. Jody Steinauer, MD, MAS University of California, San Francisco Objectives
More informationWHAT PATIENTS BRING TO THE MEDICAL ENCOUNTER DEALING WITH THE WHOLE PATIENT FACULTY PACKET
WHAT PATIENTS BRING TO THE MEDICAL ENCOUNTER DEALING WITH THE WHOLE PATIENT FACULTY PACKET Faculty Introduction to the Case The overall objective of this case is to provide students with an opportunity
More informationLessons Learned from HPV Vaccine Study Among Young Adult Women and Men
Lessons Learned from HPV Vaccine Study Among Young Adult Women and Men Natalie Joseph, MD, MPH Assistant Professor of Pediatrics/Adolescent Medicine Boston University Medical Center Racial and ethnic differences
More informationCervical screening. Cytology-based screening programmes
HPV-FASTER: broadening the scope for prevention of HPV-related cancer Combining the complementary approaches of HPV vaccination and screening could accelerate declines in the burden of cervical cancer
More informationStudy of awareness about early detection of cervical cancer by pap smear screening amongst women of Bhavnagar District
Original Research Article Study of awareness about early detection of cervical cancer by pap smear screening amongst women of Bhavnagar District Vandana N Patel 1, Piyush K Solanki 2, Harshid L Patel 3*
More informationDe-Sexualizing the HPV Vaccine How to Counsel Your Families
De-Sexualizing the HPV Vaccine How to Counsel Your Families Laura J. Benjamins, MD, MPH Assistant Professor, Adolescent Medicine The University of Texas Medical School, Houston Objectives Understand current
More informationAttitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK
British Journal of Cancer (2003) 88, 42 46 All rights reserved 0007 0920/03 $25.00 www.bjcancer.com Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean
More informationTitle: Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women
Author's response to reviews Title: Seroprevalence of Human Papillomavirus Types 6, 11, 16 and 18 in Chinese Women Authors: Jia Ji (jackie.j.ji@gmail.com) He Wang (hewangpeking@gmail.com) Jennifer S. Smith
More informationSAGE evidence to recommendations framework i
SAGE evidence to recommendations framework i Question: What is the public health impact on cervical cancer of administering HPV vaccine to 9 to 15-year old females and males versus to 9 to 15-year old
More informationFaculty Pap Smear Guidelines: Family Planning Update 2008 Part Two
Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two Seshu P. Sarma, MD, FAAP Emory University Regional Training Center Atlanta, Georgia Produced by the Alabama Department of Public Health
More informationCervical Cancer Screening. David Quinlan December 2013
Cervical Cancer Screening David Quinlan December 2013 Cervix Cervical Cancer Screening Modest variation provincially WHO and UK begin at 25 stop at 60 Finland begin at 30 stop at 60 Rationale for
More informationEradicating Mortality from Cervical Cancer
Eradicating Mortality from Cervical Cancer Michelle Berlin, MD, MPH Vice Chair, Obstetrics & Gynecology Associate Director, Center for Women s Health June 2, 2009 Overview Prevention Human Papilloma Virus
More informationHuman Papillomavirus. Kathryn Thiessen, ARNP, ACRN The Kansas AIDS Education and Training Center The University of Kansas School of Medicine Wichita
Human Papillomavirus Kathryn Thiessen, ARNP, ACRN The Kansas AIDS Education and Training Center The University of Kansas School of Medicine Wichita What is Genital HPV Infection Human papillomavirus is
More informationCervical cancer screening in vaccinated population
Cervical cancer screening in vaccinated population Cytology and molecular testing Prof. Dr. Fuat Demirkıran I.U Cerrahpaşa School of Medicine. Department of OB&GYN Division Of Gynocol Oncol Izmir, November
More informationHPV Testing & Cervical Cancer Screening:
HPV Testing & Cervical Cancer Screening: Are they linked? By William Chapman, MD, FRCPC Screening for precursor lesions of cervical cancer by the Papanicolaou (Pap) smear has been one of the greatest success
More informationThe new Cervical Screening Test for Australian women: Louise Farrell
The new Cervical Screening Test for Australian women: Louise Farrell Outline and explain the changes to the National Cervical Screening Program due to commence in Dec 2017 LEARNING OBJECTIVES FOR TODAY
More informationCervical Cancer Screening Guidelines Update
Frontier AIDS Education and Training Center Cervical Cancer Screening Guidelines Update Hillary Liss, MD Harborview Medical Center, Madison and Adult Medicine Clinics Frontier AETC, Medical Program Director
More informationParental Attitudes toward Human Papilloma Virus Vaccine Participation of Adolescent Daughters in a Rural Population
Diversity and Equality in Health and Care (2018) 15(4): 164-168 2018 Insight Medical Publishing Group Research Article Parental Attitudes toward Human Papilloma Virus Vaccine Participation of Adolescent
More information1 Cervical Cancer Prevention and Screening: Update 2010 Michael S. Policar, MD, MPH Clinical Professor of Ob, Gyn, and RS UCSF School of Medicine policarm@obgyn.ucsf.edu No commercial disclosures for this
More informationCase Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure
Disclosure Workshop: Case Management of Abnormal Pap Smears and Colposcopies Rebecca Jackson, MD Associate Professor Obstetrics, Gynecology & Reproductive Sciences and Epidemiology & Biostatistics This
More informationThe new European (and Italian) guidelines for cervical screening will recommend PAP from 25 to 34 HPV (+ triage) from 35 to 64
The new European (and Italian) guidelines for cervical screening will recommend PAP from 25 to 34 HPV (+ triage) from 35 to 64 risk of overdiagnosis and over treatment Failures in reproductive functioning:
More informationKNOWLEDGE, PERCEPTION, AND ACCEPTANCE OF HPV VACCINATION AND SCREENING FOR CERVICAL CANCER AMONG WOMEN IN YOGYAKARTA PROVINCE, INDONESIA
KNOWLEDGE, PERCEPTION, AND ACCEPTANCE OF HPV VACCINATION AND SCREENING FOR CERVICAL CANCER AMONG WOMEN IN YOGYAKARTA PROVINCE, INDONESIA Dwi Endarti*, Satibi, Susi Ari Kristina, Muhaya Almira Farida, Yuni
More informationASCCP Guideline Changes and Management of the Abnormal Pap Test Accurately Targeting Intervention
ASCCP Guideline Changes and Management of the Abnormal Pap Test Accurately Targeting Intervention Beryl Manning-Geist MD a,c, Allison Vitonis Sc. M. a, Michelle Davis MD a,b, Sarah Feldman MD MPH a,b a
More informationHUMAN PAPILLOMAVIRUS; Knowledge and Vaccine Acceptance Among Undergraduates In a Tertiary Institution in Southeast Nigeria.
HUMAN PAPILLOMAVIRUS; Knowledge and Vaccine Acceptance Among Undergraduates In a Tertiary Institution in Southeast Nigeria. Authors: Uzoma M. Agwu, Chinwe C.C. Obianyo Grace Umahi Presented at the 28 th
More informationLessons From Cases of Screened Women Who Developed Cervical Carcinoma
Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases
More informationWhat is a Pap smear?
Pap smear What is a Pap smear? A Pap smear is a test that checks for changes in the cells of your cervix. The cervix is the lower part of the uterus that opens into the vagina. Developed over forty years
More informationExploring Current Practices, Knowledge, and Attitudes Regarding HPV and Vaccine among Minnesota Dentists and Hygienists
Exploring Current Practices, Knowledge, and Attitudes Regarding HPV and Vaccine among Minnesota Dentists and Hygienists Cyndee Stull, MSDH Clinical Assistant Professor Human Papillomavirus #1 80-90% 50%
More information12/4/18 HPV VACCINATION IN MASSACHUSETTS AND BEYOND VANUCCI DISCLOSURE OBJECTIVES VACCINE BENEFITS VACCINE COMMUNICATION WORLD
HPV VACCINATION IN MASSACHUSETTS AND BEYOND Rebecca Vanucci, MA 6 th Annual HPV-Related Cancer Summit November 30, 2018 1 2 VANUCCI DISCLOSURE OBJECTIVES I, Rebecca Vanucci, have been asked to disclose
More informationAcceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index
DOI 10.1007/s00404-012-2569-y GYNECOLOGIC ONCOLOGY Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index Hadi Shojaei Fariba Yarandi Leila
More informationEffect of human papillomavirus vaccination on cervical cancer screening in Alberta
Effect of human papillomavirus vaccination on cervical cancer screening in Alberta Presenter: Jong Kim 1 Team: Christopher Bell 2, Maggie Sun 3, Gordon Kliewer 3, Linan Xu 3, Maria McInerney 4, Lawrence
More informationNIH Public Access Author Manuscript Sex Transm Infect. Author manuscript; available in PMC 2013 June 21.
NIH Public Access Author Manuscript Published in final edited form as: Sex Transm Infect. 2012 June ; 88(4): 264 265. doi:10.1136/sextrans-2011-050197. Advertisements promoting HPV vaccine for adolescent
More informationCervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013
Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely
More informationHPV & CERVICAL CANCER POLICY & LEGISLATIVE TOOLKIT, 3 RD EDITION
HPV Vaccine FAST FACTS: Payer & Reimbursement Strategies Medicaid: Many state Medicaid programs cover the HPV vaccine, though this coverage varies by state. Information on coverage can be found through
More informationRESEARCH ARTICLE. Abstract. Introduction
DOI:http://dx.doi.org/10.7314/APJCP.2015.16.16.6857 Cost-Effectiveness of Strategies for Detection CIN2+ in Women with ASC-US Pap Smears in Thailand RESEARCH ARTICLE Cost-Effectiveness Analysis of Different
More informationDepartment of Health Standard for the Cervical Cancer Screening Program. Approval Date: 08 May 2018 Effective Date: 13 May 2018
Document Title: Department of Health Standard for the Cervical Cancer Screening Program Document Ref. Number: DOH/CCSC/SD/1.0 Version: 1.0 Approval Date: 08 May 2018 Effective Date: 13 May 2018 Last Reviewed:
More informationIndex. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.
Infect Dis Clin N Am 19 (2005) 563 568 Index Note: Page numbers of article titles are in boldface type. A Abstinence in genital herpes management, 436 Abuse sexual childhood sexual behavior effects of,
More informationHPV Vaccination. Dr. Vivien Tsu PATH. HPV Vaccination 1
HPV Vaccination Dr. Vivien Tsu PATH HPV Vaccination 1 HPV vaccine overview 1 First vaccines to focus on a female cancer. Prepared from virus-like particles (VLPs). VLPs are non-infectious. Two vaccines
More informationCervical Cancer 4/27/2016
Guidelines for Cervical Cancer Screening and Prevention Management of Abnormal Results Kathy A. King, MD Assistant Professor of OB/GYN Medical College of Wisconsin May 6, 2016 Cervical Cancer In US about
More informationNatoshia M. Askelson, MPH, PhD Elizabeth T. Momany, PhD Mesay Tegegne Stephanie Edmonds, RN, MPH
Natoshia M. Askelson, MPH, PhD Elizabeth T. Momany, PhD Mesay Tegegne Stephanie Edmonds, RN, MPH This work was supported by Grant IRG-77-004-34 from the American Cancer Society, administered through the
More informationHPV VACCINE COVERAGE IN APPALACHIAN VS. NON- APPALACHIAN OHIO
HPV VACCINE COVERAGE IN APPALACHIAN VS. NON- APPALACHIAN OHIO NEWSPAPERS JANICE RAUP-KRIEGER, PHD The Ohio State University Newspapers as a Source of Health Information in Appalachia Media as a source
More informationUnderstanding of Senile Dementia by Children and Adolescents: Why Grandma Can t Remember Me?
138 Understanding of Senile Dementia by Children and Adolescents: Why Grandma Can t Remember Me? Jong-Ling Fuh 1, Shuu-Jiun Wang 1, and Kai-Di Juang 2 Abstract- Background: The present study sought to
More informationTo test or not to test: A psychosocial perspective of HIV testing
To test or not to test: A psychosocial perspective of HIV testing John B.F. de Wit, Ph.D. Utrecht University Philippe C.G. Adam, Ph.D. Institute for Prevention and Social Research Research questions What
More informationClinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening
Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening Clinical Policy Number: 01.01.02 Effective Date: April 1, 2015 Initial Review Date: January 21, 2015 Most Recent
More informationPrevention of HPV Disease What we know in 2012
Prevention of HPV Disease What we know in 2012 1952 HPV was discovered 1978 - HPV was first identified in skin cancer History 1982 - connection between HPV 16 and 18 and cervical cancer was established
More informationAbility to work with difference (working in a culturally competent manner)
Ability to work with difference (working in a culturally competent manner) There are many factors that need to be considered in the development of culturally competent practice, and finding a language
More informationCervical Screening for Dysplasia and Cancer in Patients with HIV
Cervical Screening for Dysplasia and Cancer in Patients with HIV Adult Clinical Guideline from the New York State Department of Health AIDS Institute w w w.hivg uidelines.org Purpose of the Guideline Increase
More informationNatural History of HPV Infections 15/06/2015. Squamous cell carcinoma Adenocarcinoma
14,670 5796 United States/ Canada 17,165 8124 Central America 48,328 21,402 South America 59,929 29,814 Europe 78,896 61,670 Africa 157,759 86,708 Southcentral Asia 61,132 31,314 Eastern Asia 42,538 22,594
More informationPROJECT: APPLYING ADVANCED ANALYTICS TO HELP IMPROVE MENTAL HEALTH AMONG HIV POSITIVE ADOLESCENTS IN SOUTH AFRICA
DATA PHILANTHROPY: A CASE STUDY CLIENT: SHM FOUNDATION PROJECT: APPLYING ADVANCED ANALYTICS TO HELP IMPROVE MENTAL HEALTH AMONG HIV POSITIVE ADOLESCENTS IN SOUTH AFRICA John Snow Labs are professional,
More informationLuciano Mariani Istituto Nazionale Tumori Regina Elena, Roma
Luciano Mariani Istituto Nazionale Tumori Regina Elena, Roma SANIT 2008 PREVENZIONE SECONDARIA DEI TUMORI DELLA MAMMELLA, CERVICE UTERINA E COLONRETTO Roma, 24 giugno 2008 1. Vaccination and cytologic
More informationLauren O Sullivan, D.O. February 19, 2015
Lauren O Sullivan, D.O. February 19, 2015 1. Review basics of Pap smear, cervical dysplasia/cancer and HPV infection. 2. Review 2012 updated screening guidelines. 3. Discuss how and where to find updated
More informationPSYCHOSOCIAL BURDEN OF ABNORMAL PAP SMEARS AMONG HIV-INFECTED WOMEN AT CHON BURI HOSPITAL, THAILAND
PSYCHOSOCIAL BURDEN OF ABNORMAL PAP SMEARS AMONG HIV-INFECTED WOMEN AT CHON BURI HOSPITAL, THAILAND Mangala PH Jayathunge 1, Chureeratana Bowanwatanuwong 2, Wirach Maek-a-nantawat 1, Benjaluck Phonrat
More informationWhat factors are associated with male acceptance of the human papillomavirus vaccine?
The University of Toledo The University of Toledo Digital Repository Master s and Doctoral Projects What factors are associated with male acceptance of the human papillomavirus vaccine? Stacey Marie Boswell
More informationExploring of Cervical Cancer s Knowledge among Female Nursing Students Based on Junior and Senior grades information
IOSR Journal of Nursing and Health Science (IOSR-JNHS) e-issn: 2320 1959.p- ISSN: 2320 1940 Volume 4, Issue 2 Ver. II (Mar.-Apr. 2015), PP 08-13 www.iosrjournals.org Exploring of Cervical Cancer s Knowledge
More informationIntention to Accept Pandemic H1N1 Vaccine and the Actual Vaccination Coverage in Nurses at a Chinese Children's Hospital
HK J Paediatr (new series) 2011;16:101-106 Intention to Accept Pandemic H1N1 Vaccine and the Actual Vaccination Coverage in Nurses at a Chinese Children's Hospital SS HU, LL YANG, SH CHEN, XF WANG, YF
More informationPerceived stigmatisation of patients with mental illness and its psychosocial correlates: a prospective cohort study
COMMISSIONED RESEARCH ON MENTAL HEALTH POLICY AND SERVICES Perceived stigmatisation of patients with mental illness and its psychosocial correlates: a prospective cohort study WT Chien *, SWC Chan, FKK
More informationKNOWLEDGE, ATTITUDES, AND ACCEPTABILITY OF A HUMAN PAPILLOMAVIRUS VACCINE AMONG HEALTHCARE PROVIDERS
KNOWLEDGE, ATTITUDES, AND ACCEPTABILITY OF A HUMAN PAPILLOMAVIRUS VACCINE AMONG HEALTHCARE PROVIDERS Archin Songthap 1, Punnee Pitisuttithum 2, Jaranit Kaewkungwal 1, Wijitr Fungladda 3, Valai Bussaratid
More informationWELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1
WELL WOMAN CLINIC-SCREENING PROGRAM FOR CERVICAL CARCINOMAS G. J. Vani Padmaja 1 HOW TO CITE THIS ARTICLE: G. J. Vani Padmaja. Well Woman Clinic-Screening Program for Cervical Carcinomas. Journal of Evolution
More informationColposcopy. Attila L Major, MD, PhD
Colposcopy Attila L Major, MD, PhD Histology Colposcopy Cytology It has been estimated that annual Pap smear testing reduces a woman s chance of dying of cervical cancer from 4 in 1000 to about 5 in 10,000
More informationHPV Vaccination Rates
HPV Vaccination Rates Jennifer E. Dietrich MD, MSc Fellowship Director Pediatric and Adolescent Gynecology, Division of Pediatric and Adolescent Gynecology Department of Obstetrics and Gynecology Department
More informationThe Chinese University of Hong Kong The Nethersole School of Nursing. CADENZA Training Programme
The Chinese University of Hong Kong The Nethersole School of Nursing CTP003 Chronic Disease Management and End-of-life Care Web-based Course for Professional Social and Health Care Workers Copyright 2012
More informationwww. russellresearch.com
0 Introduction and Methodology Study Overview The purpose of this study was to understand familiarity, perceptions, and behavior as it relates to human papillomavirus (HPV), hepatitis B, and hepatitis
More informationName of Policy: Speculoscopy
Name of Policy: Speculoscopy Policy #: 095 Latest Review Date: September 2011 Category: Medicine/OB Gyn Policy Grade: C Background/Definitions: As a general rule, benefits are payable under Blue Cross
More informationHow do we compare? IP724/BMTRY Introduction to Global and Public Health. Feb 21, 2012 Basic Science Rm Sharon Bond, PhD, CNM
Eradicating Cervical Cancer: Our Global Imperative College of Nursing February 2012 What is cervical cancer? Why do we care? 2 nd leading cause of cancer deaths among women worldwide (after breast ca)
More informationCINtec PLUS and the Pap smear: a co-testing alternative
CINtec PLUS and the Pap smear: a co-testing alternative Rosemary Tambouret MD p16/ki67 (CINtec PLUS) and the Pap smear Rosemary Tambouret MD CINtec PLUS dual stain: p16 and Ki67 p16 is anti-proliferative
More informationSilvia Franceschi Infections and Cancer Epidemiology Group International Agency for Research on Cancer Lyon, France
From epidemiology to cancerpreventing vaccines: the example of HPV Silvia Franceschi Infections and Cancer Epidemiology Group International Agency for Research on Cancer Lyon, France Milan, 19 March 2007
More informationClinical outcomes after conservative management of CIN1/2, CIN2, and CIN2/3 in women ages years
Clinical outcomes after conservative management of CIN1/2, CIN2, and CIN2/3 in women ages 21-39 years Michelle I. Silver, PhD, ScM Cancer Prevention Fellow National Cancer Institute Division of Cancer
More informationIJPHCS Open Access: e-journal
KNOWLEDGE OF HPV AND HPV VACCINATION AND THE ASSOCIATED FACTOR AMONG PRIMIGRAVIDAS IN A TERTIARY HOSPITAL Noor Sa adah Azmin 1, Kasmah Wati Pardi 2* 1 The National Heart Institute of Malaysia (IJN). 2
More informationL impact attendu de la vaccination contre le virus du papillome humain sur les pratiques de dépistage du cancer du col uterin
10 es Journées annuelles de santé publique Palais des congrès de Montréal 23 au 27 octobre 2006 L impact attendu de la vaccination contre le virus du papillome humain sur les pratiques de dépistage du
More informationStudy Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationThe Biology of HPV Infection and Cervical Cancer
The Biology of HPV Infection and Cervical Cancer Kaitlin Sundling, M.D., Ph.D. Clinical Instructor Faculty Director, Cytotechnology Program Wisconsin State Laboratory of Hygiene and University of Wisconsin
More information